<p>Cutempa Medical Ltd is a medical device company, developing a platform for the treatment of chronic and acute wounds. First focus is diabetic food ulcer, as this is an urgent global issue with 20 million patients globally. The initial products are mineral based and will be converted into an microparticle powder with large surface area by a specific manufacturing process. The product patents have been submitted for Europe, North America, China. Early interest from Global Wound Players has already been raised. The pivotal study is approved by the ethics and the BfArM and start on July 22nd 2026. The study results are expected in 12 months from this timepoint. </p>